Novolog® Mix 70/30 (70% insulin aspart protamine suspension and 30% insulin aspart injection, [rDNA origin]), a dual-action insulin analog that does not contain NPH insulin, is more effective in ...

Princeton, NJ (September 27, 2004) – In type 2 diabetes patients, use of NovoLog® Mix 70/30 FlexPen® (70% insulin aspart protamine suspension and 30% insulin aspart injection, [rDNA origin]), a ...

PRINCETON, N.J., Aug. 25 /PRNewswire/ -- Novo Nordisk announced today the availability of NovoDose™– the first-ever mobile insulin dosing guide for physicians to look up dosing guidelines and blood ...

PRINCETON, N.J., Jan. 27 /PRNewswire-FirstCall/ -- According to a two-year head-to-head study published today in the European Journal of Internal Medicine, patients ...

Sept. 15, 2005 — The U.S. Food and Drug Administration (FDA) and Novo Nordisk, Inc., have notified pharmacists via letter of changes to the packaging for a rapid-acting insulin analog (NovoLog) that ...

Please provide your email address to receive an email when new articles are posted on . Novo Nordisk announced that it will offer “authorized generic” versions of ...

Novo Nordisk A/S (NYSE: NVO) is lowering the U.S. list prices of some insulin products by up to 75%. Products include prefilled pens and vials of basal (long-acting), bolus (short-acting), and pre-mix ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Insulin Aspart: Key Patent, SPC, and Data Exclusivity Expiry - 44 Country Coverage" report to their offering. Pipeline ...

Novo Nordisk will start slashing some U.S. insulin prices up to 75 percent next year, following a path set earlier this month by rival Eli Lilly. The Danish drugmaker said Tuesday that pre-filled pens ...

LONDON, GREATER LONDON, UNITED KINGDOM, February 7, 2025 /EINPresswire / -- Is the Novolog Mix 70/30 Market Set to Witness Substantial Growth? The Novolog Mix 70 or ...

Please provide your email address to receive an email when new articles are posted on . Novo Nordisk is the latest company to announce a large reduction in insulin prices as it stated it will cut ...

In patients treated with NovoLog (R) Mix 70/30, glucose infusion rates rose more rapidly and reached a higher peak compared to insulin glargine and overall plasma insulin was also significantly ...